Subacute and Long-Term Hepatotoxicity Risk after 90Y-OR 177LU-DOTATOC Therapy - Is Hepatic Tumour Burden on 68Ga-DOTATOC PET/CT Predictive of Liver Dysfunction?

被引：0
|
作者：
Chirindel, A. [1 ]
Anongpornjossakul, Y. [2 ]
Wild, D. [1 ]
Nicolas, G. [1 ]
机构：
[1] Univ Hosp Basel, Basel, Switzerland
[2] Mahidol Univ, Ramathibodi Hosp, Bangkok, Thailand
来源：
NEUROENDOCRINOLOGY | 2019年 / 108卷
关键词：
prrt; neuroendocrine tumour; hepatic dysfunction; liver segmentation;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
K10
引用
收藏
页码：204 / 204
页数：1
相关论文
共 17 条
  • [1] 68Ga DOTATOC PET/CT for treatment response of Peptide Receptor Radionuclide Therapy using 177Lu and 90Y-DOTATOC
    Finocchiaro, D.
    Grassi, E.
    Fioroni, F.
    Castellani, G.
    Lanconelli, N.
    Versari, A.
    Filice, A.
    Iori, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S288 - S288
  • [2] Multimodal Imaging for Early Functional Response Assessment of 90Y-/177Lu-DOTATOC Peptide Receptor Targeted Radiotherapy with DW-MRI and 68Ga-DOTATOC-PET/CT
    Wulfert, Sarah
    Kratochwil, Clemens
    Choyke, Peter L.
    Afshar-Oromieh, Ali
    Mier, Walter
    Kauczor, Hans-Ulrich
    Schenk, Jens-Peter
    Haberkorn, Uwe
    Giesel, Frederik L.
    MOLECULAR IMAGING AND BIOLOGY, 2014, 16 (04) : 586 - 594
  • [3] Multimodal Imaging for Early Functional Response Assessment of 90Y-/177Lu-DOTATOC Peptide Receptor Targeted Radiotherapy with DW-MRI and 68Ga-DOTATOC-PET/CT
    Sarah Wulfert
    Clemens Kratochwil
    Peter L. Choyke
    Ali Afshar-Oromieh
    Walter Mier
    Hans-Ulrich Kauczor
    Jens-Peter Schenk
    Uwe Haberkorn
    Frederik L. Giesel
    Molecular Imaging and Biology, 2014, 16 : 586 - 594
  • [4] Somatostatin Receptor-Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial
    Marincek, Nicolas
    Radojewski, Piotr
    Dumont, Rebecca A.
    Brunner, Philippe
    Mueller-Brand, Jan
    Maecke, Helmut R.
    Briel, Matthias
    Walter, Martin A.
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (02) : 171 - 176
  • [5] 68Ga-DOTATOC PET/CT after 1 cycle of PRRT with 90Y-DOTATOC visualizes changes in somatostatin receptor availability in neuroendocrine tumours
    Van Binnebeek, S.
    Mottaghy, F. M.
    Koole, M.
    Baete, K.
    Vanbilloen, B.
    Terwinghe, C.
    Clement, P.
    Verbruggen, A.
    Mortelmans, L.
    Van Cutsem, E.
    Haustermans, K.
    Verslype, C.
    Deroose, C. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S367 - S367
  • [6] Peptide receptor radionuclide therapy with Y-90 DOTATOC and Lu-177 DOTATATE in patients with progressive meningioma and prognostic value of pretherapeutic Ga-68 DOTATOC/-TATE PET/CT
    Ilhan, Harun
    Seystahl, Katharina
    Veit, Stoecklein
    Schueller, Ulrich
    Rushing, Elisabeth
    Nicolas, Guillaume
    Schaefer, Niklaus
    Pangalu, Athina
    Lehner, Sebastian
    Bartenstein, Peter
    Michael, Weller
    Tonn, Joerg
    Sommerauer, Michael
    Albert, Nathalie
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [7] Diffusion-weighted MRI and (68)Ga-DOTATOC PET for early monitoring of response to intraarterial(90)Y-/(177)Lu-DOTATOC therapy in patients with neuroendocrine liver metastases
    Giesel, F.
    Wulfert, S.
    Kuder, T.
    Kauczor, H.
    Schwartz, L.
    Haberkorn, U.
    Kratochwil, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S289 - S289
  • [8] Long-term evaluation of renal toxicity after receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE
    Bodei, L.
    Cremonesi, M.
    Grana, C.
    Bartolomei, M.
    Rocca, P. A.
    Ferrari, M.
    Baio, S. M.
    Paganelli, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S214 - S214
  • [9] Diffusion- weighted MRI and Ga68-DOTATOC PET for early monitoring of response to intra-arterial Y90/Lu177-DOTATOC therapy in patients with neuroendocrine liver metastases
    Giesel, Frederik
    Wulfert, Sarah
    Kuder, Tristan
    Schwartz, Lawrence
    Kauczor, Hans-Ulrich
    Haberkorn, Uwe
    Kratochwil, Clemens
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [10] Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
    Lisa Bodei
    Marta Cremonesi
    Mahila Ferrari
    Monica Pacifici
    Chiara M. Grana
    Mirco Bartolomei
    Silvia M. Baio
    Maddalena Sansovini
    Giovanni Paganelli
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1847 - 1856
12